<SEC-DOCUMENT>0001716774-26-000014.txt : 20260430
<SEC-HEADER>0001716774-26-000014.hdr.sgml : 20260430
<ACCEPTANCE-DATETIME>20260430082136
ACCESSION NUMBER:		0001716774-26-000014
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260430
DATE AS OF CHANGE:		20260430

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			uniQure N.V.
		CENTRAL INDEX KEY:			0001590560
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88012
		FILM NUMBER:		26920264

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		PAASHEUVELWEG 25A
		CITY:			AMSTERDAM
		PROVINCE COUNTRY:   	P7
		ZIP:			1105 BP
		BUSINESS PHONE:		1-339-970-7000

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		PAASHEUVELWEG 25A
		CITY:			AMSTERDAM
		PROVINCE COUNTRY:   	P7
		ZIP:			1105 BP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	uniQure B.V.
		DATE OF NAME CHANGE:	20131030

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aberdeen Group plc
		CENTRAL INDEX KEY:			0001716774
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		1 GEORGE STREET
		CITY:			EDINBURGH
		STATE:			X0
		ZIP:			EH2 2LL
		BUSINESS PHONE:		0131 245 2552

	MAIL ADDRESS:	
		STREET 1:		1 GEORGE STREET
		CITY:			EDINBURGH
		STATE:			X0
		ZIP:			EH2 2LL

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	abrdn plc
		DATE OF NAME CHANGE:	20210707

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Standard Life Aberdeen plc
		DATE OF NAME CHANGE:	20170912
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:ns1="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001085146-25-004357</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001716774</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>3</amendmentNo>
      <securitiesClassTitle>Ordinary Shares, par value(euro)0.05 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>04/01/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001590560</issuerCik>
        <issuerName>uniQure N.V.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>N90064101</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <ns1:street1>PAASHEUVELWEG 25A</ns1:street1>
          <ns1:city>AMSTERDAM</ns1:city>
          <ns1:stateOrCountry>P7</ns1:stateOrCountry>
          <ns1:zipCode>1105 BP</ns1:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Aberdeen Group plc</reportingPersonName>
      <citizenshipOrOrganization>X0</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>5306386</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>5306386</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>5306383</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>8.49</classPercent>
      <typeOfReportingPerson>HC</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>abrdn Inc.</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>5306386</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>5306386</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>5306386</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>8.49</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>uniQure N.V.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>PAASHEUVELWEG 25A, AMSTERDAM, NETHERLANDS
1105 BP</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Aberdeen Group plc

abrdn Inc.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Aberdeen Group plc:
1 George Street
Edinburgh, United Kingdom
EH2 2LL

abrdn Inc.
1900 Market Street Suite 200.
Philadelphia,
PA 19103</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Aberdeen Group plc - UNITED KINGDOM

abrdn Inc. - UNITED STATES</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>HC</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>5,306,386</amountBeneficiallyOwned>
        <classPercent>8.49</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>Aberdeen Group plc - 0

abrdn Inc. - 0</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>Aberdeen Group plc - 5,306,386

abrdn Inc. - 5,306,386</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>Aberdeen Group plc - 0

abrdn Inc. - 0</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>Aberdeen Group plc - 5,306,386

abrdn Inc. - 5,306,386</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>N</notApplicableFlag>
        <subsidiaryIdentificationAndClassification>See Exhibit</subsidiaryIdentificationAndClassification>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <exhibitInfo>Aberdeen Group plc
abrdn Holdings Limited
abrdn Inc.

Aberdeen Group plc is the parent company.
abrdn Holdings Limited is the intermediate holding company for abrdn Inc.
abrdn Inc. beneficially owns on behalf of our underlying clients 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G.</exhibitInfo>
    <signatureInformation>
      <reportingPersonName>Aberdeen Group plc</reportingPersonName>
      <signatureDetails>
        <signature>Frederic Osei</signature>
        <title>Frederic Osei, Major Shareholding Reporting Analyst</title>
        <date>03/31/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>abrdn Inc.</reportingPersonName>
      <signatureDetails>
        <signature>Frederic Osei</signature>
        <title>Frederic Osei, Major Shareholding Reporting Analyst</title>
        <date>03/31/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
